Which hedge funds own MGX? METAGENOMI THERAPEUTICS INC, Q2 2026 13F holders
6 of the hedge funds tracked by WhaleCreep disclosed a position in MGX (METAGENOMI THERAPEUTICS INC) in their Q2 2026 13F filings, worth $1.7m in total. The largest holder by portfolio weight is Pura Vida Investments, LLC at 0.9% of its book. 1 manager opened a new position this quarter: Qube Research & Technologies LTD. 1 exited: Marshall Wace, LLP.
6tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold MGX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Pura Vida Investments, LLC | Q2 2026 | 0.9% | $314.6k | 264,391 | 0% | held |
| Catalio Capital Management, LP | Q2 2026 | 0.1% | $629.5k | 528,993 | 0% | held |
| Two Sigma Investments, LP | Q2 2026 | 0.0% | $611.3k | 513,701 | 3% | added |
| Millennium Management LLC | Q2 2026 | 0.0% | $135.7k | 114,025 | -33% | reduced |
| Qube Research & Technologies LTD | Q2 2026 | 0.0% | $20.1k | 16,850 | – | new |
| Citadel Advisors LLC | Q2 2026 | 0.0% | $21.2k | 17,851 | 5% | added |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Marshall Wace, LLP | 0.0% | $36.9k |
Held in a manager's last filing on record
These managers have not filed for the latest quarter; their last disclosure is dated.
| Manager | Last filing | Weight |
|---|---|---|
| renaissance | Q2 2026 | 0.0% |
How has hedge fund ownership of MGX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $2.6m |
| Q1 2026 | 8 | $3.1m |
| Q4 2025 | 2 | $1.1m |
| Q3 2025 | 1 | $395.8k |
| Q2 2025 | 1 | $176.1k |
| Q1 2025 | 1 | $135.5k |
| Q4 2024 | 1 | $555.2k |
| Q3 2024 | 3 | $5.5m |
| Q2 2024 | 3 | $11.9m |
| Q1 2024 | 3 | $36.5m |
Counts every tracked manager that disclosed MGX in that quarter's filing, including managers that have since stopped filing.